Improving Leishmaniasis Vaccine with Solid Lipid Nanoparticles
Author Information
Author(s): Doroud Delaram, Zahedifard Farnaz, Vatanara Alireza, Taslimi Yasaman, Vahabpour Rouholah, Torkashvand Fatemeh, Vaziri Behrooz, Rouholamini Najafabadi Abdolhossein, Rafati Sima
Primary Institution: Pasteur Institute of Iran
Hypothesis
Can cationic solid lipid nanoparticles enhance the immune response to a DNA vaccine against Leishmania major?
Conclusion
Cationic solid lipid nanoparticles significantly boost the immune response and protective efficacy of a DNA vaccine against Leishmania major in mice.
Supporting Evidence
- Vaccination with cSLN-pcDNA-cpa/b-CTE showed significantly higher levels of parasite inhibition.
- The average parasite inhibition percent increased significantly with cSLN formulations.
- Flow cytometry was found to be the most rapid and sensitive method for assessing vaccine efficacy.
Takeaway
Researchers found that using special tiny particles helped a vaccine work better against a disease caused by a parasite.
Methodology
BALB/c mice were immunized with various formulations of DNA vaccines and their immune responses were measured through parasite load assessments and cytokine production.
Potential Biases
Potential bias in the selection of vaccine formulations and measurement techniques.
Limitations
The study was conducted in a murine model, which may not fully replicate human responses.
Participant Demographics
Female BALB/c mice, 6-8 weeks old.
Statistical Information
P-Value
p<0.05
Confidence Interval
IC95% not specified
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website